Literature DB >> 31696470

MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells.

S-L Du1, L-Y Xu, P Gao, Q-S Liu, F-F Lu, Z-H Mo, Z-Z Fan, X-L Cheng, Z-H Dong.   

Abstract

OBJECTIVE: DJ-1 is a negative regulator of PTEN and plays a role in tumorigenesis. Abnormal miR-203 expression is associated with pancreatic cancer. Bioinformatics analysis showed a targeted relationship between miR-203 and DJ-1 3'-UTR. This study investigated whether miR-203 regulates DJ-1 expression and its role in pancreatic cancer cell proliferation, apoptosis, and cisplatin (DDP) resistance.
MATERIALS AND METHODS: The Dual-Luciferase reporter gene assay validated the targeted regulation between miR-203 and DJ-1. The DDP-resistant cell line SW1990/DDP was established and divided into miR-NC group and miR-203 mimic group followed by analysis of the expression of DJ-1, PTEN and p-AKT, cell apoptosis, and proliferation.
RESULTS: There was a targeted relationship between miR-203 and DJ-1 mRNA. The expression of miR-203 in SW1990/DDP cells was significantly lower than that in SW1990 cells, while the expression of DJ-1 mRNA and protein was significantly higher than that in SW1990 cells. Compared with miR-NC group, the expression of DJ-1 and p-AKT protein in SW1990/DDP cells was significantly decreased in miR-203 mimic transfection group, while the expression of PTEN was significantly increased with increased cell apoptosis and decreased cell proliferation, as well as reduced DDP resistance.
CONCLUSIONS: The decreased expression of miR-203 and the increased expression of DJ-1 is associated with drug resistance in pancreatic cancer cells. Elevated miR-203 can inhibit the expression of DJ-1, affect the activity of PTEN-PI3K/AKT pathway, inhibit the proliferation of pancreatic cancer cells, induce cell apoptosis, and reduce DDP resistance of pancreatic cancer cells.

Entities:  

Year:  2019        PMID: 31696470     DOI: 10.26355/eurrev_201910_19278

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

Review 1.  Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism.

Authors:  Erika Olivo; Marina La Chimia; Jessica Ceramella; Alessia Catalano; Ferdinando Chiaradonna; Maria Stefania Sinicropi; Giovanni Cuda; Domenico Iacopetta; Domenica Scumaci
Journal:  Cells       Date:  2022-04-23       Impact factor: 7.666

Review 2.  Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

Review 3.  Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer.

Authors:  Seung Wan Son; Mun Gyu Song; Ba Da Yun; Jong Kook Park
Journal:  Biomedicines       Date:  2021-03-07

Review 4.  Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma.

Authors:  Ru Wang; Hengwei Fan; Ming Sun; Zhongwei Lv; Wanwan Yi
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

5.  Cisplatin resistance-related multi-omics differences and the establishment of machine learning models.

Authors:  Qihai Sui; Zhencong Chen; Zhengyang Hu; Yiwei Huang; Jiaqi Liang; Guoshu Bi; Yunyi Bian; Mengnan Zhao; Cheng Zhan; Zongwu Lin; Qun Wang; Lijie Tan
Journal:  J Transl Med       Date:  2022-04-11       Impact factor: 5.531

Review 6.  PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Ádám Vannay
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

7.  MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2.

Authors:  Xi-Feng Fu; Hai-Chao Zhao; Chuan-Li Yang; Chang-Zhou Chen; Kang Wang; Fei Gao; Yang-Zhang Tian; Hao-Liang Zhao
Journal:  Oncol Lett       Date:  2021-06-30       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.